Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on May 23, 2025
As Bitcoin Hits New All-Time Highs, DN Miner Says It’s the Perfect Time to Add Cloud Mining to Your Strategy
GlobeNewswire
·
May 23, 2025
London, UK, May 23, 2025 (GLOBE NEWSWIRE) -- Bitcoin has once again surged past its all-time high, reigniting excitement across the crypto market and sending investor confidence soaring. But while many are celebrating record-breaking gains, DN Miner, a …
Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas
GlobeNewswire
·
May 23, 2025
WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice …
VEON and Engro Corporation Advance to Closing Pioneering Infrastructure Partnership in Pakistan Following Regulatory Approvals
GlobeNewswire
·
May 23, 2025
Islamabad and Dubai, May 23, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has now secured all regulatory approvals for its strategic partnership with Engro Corporation Limited (“Engro Corp”) for the …
Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
GlobeNewswire
·
May 23, 2025
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
GlobeNewswire
·
May 23, 2025
ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of an …
Peony Blossom Celebration: A Springtime Cultural Gathering Enchants Bulgaria
GlobeNewswire
·
May 23, 2025
SOFIA, Bulgaria, May 23, 2025 (GLOBE NEWSWIRE) -- Amidst a vibrant sea of peonies in Sofia's South Park, Bulgaria, the "Peony Blossom Celebration: A Springtime Cultural Gathering" kicked off on May 17, drawing hundreds from across the country eager to …
Voting Results from Constellium's 2025 Annual General Meeting
GlobeNewswire
·
May 23, 2025
PARIS, May 23, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) announced today that the voting results for its Annual General Meeting of Shareholders held on May 15, 2025 (the “AGM”) have been published on the Company’s website (https://www. …
VIRTUNE BESCHLEUNIGT EUROPÄISCHE EXPANSION MIT XRP-ETP-DEBÜT AN DER DEUTSCHE BÖRSE XETRA
GlobeNewswire
·
May 23, 2025
Frankfurt, 23. Mai 2025 – Der schwedische regulierte Krypto-Vermögensverwalter Virtune bringt eines seiner Flaggschiffproduket, den Virtune XRP ETP, an Deutschlands führenden Handelsplatz Deutsche Börse Xetra und erweitert damit sein reguliertes Angebot …
VIRTUNE ACCELERATES EUROPEAN EXPANSION WITH XRP ETP DEBUT ON DEUTSCHE BÖRSE XETRA
GlobeNewswire
·
May 23, 2025
Frankfurt, 23 May 2025 – Swedish regulated crypto asset manager Virtune brings its flagship Virtune XRP ETP to Germany's premier trading venue Deutsche Börse Xetra, extending its regulated digital asset offerings to Europe's largest economy. With strong …
‘Pub Delivery’: Heineken® brings fans’ matchday ritual – and their ‘lucky pub’ - with them to Lisbon for the UEFA Women’s Champions League final
GlobeNewswire
·
May 23, 2025
A Media Snippet accompanying this announcement is available in this link. AMSTERDAM, May 23, 2025 (GLOBE NEWSWIRE) -- Half of football fans have matchday rituals – and nearly as many (46%)* believe their superstitions can influence the score. For two …
Inventiva reports 2025 First Quarter Financial Information¹
GlobeNewswire
·
May 23, 2025
Cash and cash equivalents at €67.9 million Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral …
Inventiva publie ses informations financières¹ du 1er trimestre 2025
GlobeNewswire
·
May 23, 2025
Trésorerie et équivalents de trésorerie à 67,9 millions d’euros Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans …
EXEL Industries: 2024–2025 half-year results
GlobeNewswire
·
May 23, 2025
First half 2024–2025 results Priority given to reducing debt and optimizing WCR in the first half, positive net income driven by lower costs in response to lower volumes in Agricultural Spraying In the first half of 2024–2025, EXEL Industries's revenue …
EXEL Industries : résultats semestriels 2024–2025
GlobeNewswire
·
May 23, 2025
Résultats semestriels 2024–2025 Priorité à la réduction de la dette et l’optimisation du BFR au premier semestre, résultat net positif porté par la baisse des coûts en réaction à la baisse des volumes dans la Pulvérisation agricole Au premier semestre 2024 …
Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025
GlobeNewswire
·
May 23, 2025
Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic …
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 22 mai 2025
GlobeNewswire
·
May 23, 2025
Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …
Endeavour Announces Results of Annual General Meeting 2025
GlobeNewswire
·
May 23, 2025
ENDEAVOUR ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING 2025 London, 23 May 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (“the Company”) is pleased to announce that all resolutions at yesterday's annual general meeting (“AGM”) were duly passed …
FRO – First Quarter 2025 Results
GlobeNewswire
·
May 23, 2025
FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three months ended March 31, 2025: Highlights Profit of $33.3 million, or $ …
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025
GlobeNewswire
·
May 23, 2025
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025 BI 765063 in combination with programmed …
OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours
GlobeNewswire
·
May 23, 2025
OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours sur la modulation de l’immunité innée et l’activité antitumorale via le blocage de SIRPα à l’ASCO 2025 BI …